Closed Tenderocds-tedeu-265edd92-c5e0-4332-a97a-748268ef333a

Ex-Ante-Transparenzbekanntmachung § 130 a Abs. 8 SBG V ATC-Code: B02BD09; ATC-Code: B02BD31

Arzneimittelrabattvertrag § 130a Abs. 8 SGB V Arzneimittelbezeichnung: Benefix(R) Wirkstoff: Nonacog alfa ATC-Code B02BD09; Refacto AF(R) Wirkstoff: Moroctocog alfa ATC-Code B02BD31

Buyer

AOK Bayern - Die Gesundheitskasse

Value

Not provided

Published

24 Jul 2026

Closes

Not provided

Procurement details

Source

TED (EU)

Country

Germany (DE)

Procurement method

Limited

Category

Goods

Contract starts

Not provided

Contract ends

Not provided

CPV classifications

33600000

Pharmaceutical products

Lots

Lot LOT-0001 Ex-Ante-Transparenzbekanntmachung § 130 a Abs. 8 SBG V ATC-Code: B02BD09; ATC-Code: B02BD31

Value not provided

Arzneimittelrabattvertrag § 130a Abs. 8 SGB V Arzneimittelbezeichnung: Benefix(R) Wirkstoff: Nonacog alfa ATC-Code B02BD09; Refacto AF(R) Wirkstoff: Moroctocog alfa ATC-Code B02BD31

Delivery: Germany

TED notice 515196-2026

24 Jul 2026

Award notice · Web page

Contains information from TED (Tenders Electronic Daily), © European Union, reused under CC BY 4.0.